Adcock Ingram Holdings | AIP - Capitale Ordinario



Capitale Ordinario Cambiamento Data
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.21M 131K 2025-09
Aspen Pharmacare ZAR 444.02M 0 2025-12
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Life Healthcare ZAR 1.43B 11.06M 2025-12
Moderna USD 391M 2M 2025-09
Netcare ZAR 1.19B 26.79M 2025-12
Organon & Co USD 259.98M 18K 2025-09
Revvity USD 113.38M 2.7M 2025-12
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Viatris USD 1.16B 6.55M 2025-09
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12